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Background: The role of lymph node dissection (LND) for renal cell carcinoma (RCC)
is controversial. Notably, the conflicting evidence on the benefits and harms of LND
is inherently linked to the lack of consensus on both anatomic templates and extent
of lymphadenectomy. Herein, we provide a detailed overview of the most commonly
dissected templates of LND for RCC, focusing on key anatomic landmarks and patterns
of lymphatic drainage.
Methods: A systematic review of the English-language literature was performed
without time filters in July 2018 in accordance to the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) statement recommendations. The
primary endpoint was to summarize the most commonly dissected templates of LND
according to the side of RCC.
Results: Overall, 25 studies were selected for qualitative analysis. Of these, most
were retrospective. The LND template was heterogeneous across studies. Indications
and extent of LND were either not reported or not standardized in most series. The
most commonly dissected template for right-sided tumors included hilar, paracaval,
and precaval nodes, with few authors extending the dissection to the inter-aortocaval,
retrocaval, common iliac or pre/paraaortic nodes. Similarly, the most commonly
dissected template for left-sided tumors encompassed the renal hilar, preaortic and
paraaortic nodes, with few authors reporting a systematic dissection of inter-aortocaval,
retro-aortic, common iliac, or para-caval nodes.
Conclusions: In light of the unpredictable renal lymphatic anatomy and the evidence
from available prospective mapping studies, the extent of the most commonly dissected
templates might be insufficient to catch the overall anatomic pattern of lymphatic
drainage from RCC.
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INTRODUCTION
The role of lymph node dissection (LND) for renal cell carcinoma
(RCC) is controversial (1–6). Indeed, while the latest Guidelines
of the European Association of Urology (EAU) recommend
considering an extended LND in patients with adverse clinical
features and in the presence of clinically positive lymph nodes
(LN) (5), the American Urological Association (AUA) and
National Comprehensive Cancer Network (NCCN) Guidelines
stressed that LND should be performed primarily for staging and
prognostic purposes, and recommended not to perform routine
LND in patients with clinically negative nodes (4, 7).
The lack of consensus on indications and value of LND stems
from conflicting evidence on its ultimate impact on oncologic
outcomes in both non-metastatic and metastatic patients with
RCC (8–11). Yet, several factors may play a role in determining
the outcomes of this procedure, such as surgical techniques,
anatomic dissection templates and patient selection. In addition,
there is lack of definitive knowledge on the anatomy of lymphatic
drainage from RCC, which is unpredictable due to a wide
heterogeneity of lymphatic vessels anatomy (12–14), the potential
early hematogenous dissemination without LN infiltration (11,
12, 15) and the effects of local tumor progression (1).
Notably, as in other urological malignancies (16), the evidence
on the anatomic templates of LND at the time of conservative or
radical surgery for RCC is sparse and fragmentary (1, 2), making
the interpretation of its benefits and harms challenging.
Therefore, we aimed to provide a detailed overview of the
most commonly dissected templates of LND for RCC, focusing
on key anatomic landmarks and patterns of lymphatic drainage.
METHODS
Search Strategy
A systematic review of the English-language literature was
performed without time filters using the MEDLINE (via
PubMed), Cochrane Central Register of Controlled Trials and
Web of Science (WoS) databases in July 2018 using the keywords
‘lymph node dissection’ or ‘lymphadenectomy’ or ‘lymph nodes’ or
‘lymphatic drainage’ or ‘sentinel node’ or ‘mapping’ combined with
‘renal cancer’ or ‘renal cell carcinoma’ and ‘template’ or ‘landmark’
or ‘extent’. The review process was performed in accordance
to the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) statement recommendations (17). A
specific search strategy was designed using both free text and
Mesh Terms. Hand-search of bibliographies of included studies
and previous reviews on the topic was also performed to include
additional relevant studies. Two reviewers (RC and FS) carried
out the literature search independently.
Inclusion Criteria
A specific population (P), intervention (I), comparator (C),
outcome (O), and study design (S) (PICOS) framework was
specified to define study eligibility, as recommended (17). In
particular, the following criteria were outlined:
- Population (P): patients with non-metastatic or metastatic
RCC;
- Intervention (I): conservative (partial nephrectomy) or radical
(radical nephrectomy) surgery with LND;
- Comparison (C): patients undergoing surgery without LND
(this criterion was not mandatory for inclusion of the studies
in this review);
- Outcomes (O): anatomic extent of LND with detailed
reporting of side-specific templates, including upper/lower
boundaries of dissection, as well as of the number of patients
undergoing LND;
- Study design (S): randomized-controlled or
prospective/retrospective cohort studies with or without
comparison of different LND templates.
Studies with insufficient reporting of the PICOS criteria were
excluded. The primary endpoint of this review was to summarize
the most commonly dissected templates of LND according to the
side of RCC.
Systematic Review Process
Mendeley reference software (Mendeley Ltd, London, UK) was
used to identify and remove duplicates among records identified.
Overall, 4,205 articles were preliminarily identified by the
literature search. After exclusion of duplicates and articles not
related to the topic of this review (n = 2,671), two independent
reviewers (RC, FS.) screened titles and abstracts of 1,534 records.
An a priori developed screening form was created to guide study
selection. Disagreement was solved by a third party (AM), who
supervised the systematic review process. After exclusion of case
reports, book chapters, editorials, conference abstracts, animal
studies, pre-clinical studies, previous reviews, and articles not
related to the primary endpoint of this review, 103 articles were
assessed for eligibility. Finally, 25 studies fullfilling all inclusion
criteria were selected for qualitative analysis. The flow-chart
depicting the overall review process according to PRISMA is
shown in Supplementary Figure 1.
Data Extraction
Data were extracted independently by two authors (IG, TT)
in a-priori developed data extraction form. This included all
relevant information on the anatomic landmarks of LND and on
all elements of the PICOS framework, including study design,
patient population, RCC characteristics and pathologic stage,
indication for LND, extent of LND, LND metrics (number of
LNs removed and of positive LNs, if provided) and specific
description of LND templates according to tumor side (Table 1).
A narrative form was used for qualitative data synthesis.
RESULTS
Characteristics of Included Study and
Quality of Reporting LND Templates
The key characteristics and findings of the studies included
in the review are shown in Table 1. Of the 25 studies
included in final qualitative analysis, 21 were retrospective,
either single- (n = 17) or multicenter (n = 4), while 3
were prospective single-center. One multicenter randomized-
controlled trial (RCT) was included (15). Only two studies
were specifically designed to evaluate the pattern of lymphatic
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drainage from RCC by using sequential lymphoscintigraphy and
sentinel node (SN) biopsy (30, 37). No study compared LN
yield, cancer control and surgical complications of extended vs.
limited LND. Risk of bias assessment for the studies included
in the review is depicted in Supplementary Table 1. Overall, the
quality of evidence according to Grading of Recommendations
Assessment, Development, and Evaluation (GRADE) is low.
Overall, the proportion of patients undergoing LND was
heterogeneous across included studies and indications for LND
were not standardized in most series, being based on surgeon’s
preference and/or according to intraoperative suspicion of LN
metastases (Table 1). Most studies described an open surgical
approach for both nephrectomy and LND. A minimally invasive
approach was used in selected series, using either a laparoscopic
(n = 7) (8, 10, 24, 25, 30, 34, 35) or robotic approach (n = 1)
(29). Pathologic tumor stage was heterogeneous across included
studies, although most series considered locally advanced tumors
(pT stage 3–4) (15, 22, 23, 28, 34, 35, 39). One study examined
the role of LND at the time of cytoreductive nephrectomy (8).
The overall number of LNs removed at the time of surgery
(10, 19, 22–25, 28–34, 36–39), as well as the proportion of
positive LNs, were reported by the majority of included studies,
despite the latter was highly variable across the included studies
(range 0–56,8%) (Table 1). Of note, only a minority of reports
described the specific anatomic location (and number) of positive
nodes (19, 25, 28, 30, 34, 37–39). All included studies reported
a side-specific anatomical template of LND, with description of
the anatomical boundaries and upper/lower limits of dissection;
yet, indications and extent (i.e., standard vs. extended) of LND
were either not reported or not standardized in most series.
Furthermore, only few authors reported the lateral landmarks of
dissection for the paracaval/paraaortic templates [i.e., the right
and left ureter, respectively (10)].
The overview of the most commonly dissected templates of
LND for RCC according to tumor side is shown in Figure 1,
while a detailed analysis of the specific templates considered in
each study included in the review in Table 1. Of note, it was not
possible to define a putative pattern of lymphatic spread from
RCC due to lack of information on the location of positive LNs
within the anatomical sites of the template in most series.
Templates of Lymph Node Dissection for
Right-Sided RCC
For right-sided tumors, the LND template included in most cases
the hilar, paracaval (on the lateral side of the vena cava), and
precaval (i.e., on the anterior side of the vena cava) nodes, from
the crus of the diaphragm to the aortic bifurcation (Table 1).
Some authors reported the dissection of a more extended
template including the inter-aortocaval (8, 15, 19, 20, 25, 28–30,
32–35, 37, 39), retrocaval (8, 15, 19–21, 23, 27, 29, 32, 35, 37, 38),
common iliac (25) nodes or even pre/paraaortic nodes (19). In
their retrospective study on the outcomes of laparoscopic radical
nephrectomy with or without LND, Chapman et al. included the
FIGURE 1 | Overview of the most commonly dissected templates of lymph node dissection (LND) for renal cell carcinoma (RCC) according to tumor side (A.
Right-sided tumors; B. Left-sided tumors). (A) For right-sided tumors, LND included in most cases (continuous line) the renal hilar, paracaval, and precaval nodes,
from the crus of the diaphragm to the aortic bifurcation (in blue). Extended LND (dotted line) also included the inter-aortocaval/retrocaval nodes and the right common
iliac nodes (in yellow). (B). For left-sided tumors, LND included in most cases (continuous line) the renal hilar, preaortic, and paraaortic nodes, from the crus of the
diaphragm to the aortic bifurcation (in blue). Extended LND (dotted line) also included the inter-aortocaval/retroaortic nodes and the left common iliac nodes (in yellow).
A, aorta; CIA, common iliac artery; CIV, common iliac vein; IMA, inferior mesenteric artery; IVC, inferior vena cava; RA, renal artery; RV, renal vein; SMA, superior
mesenteric artery.
Frontiers in Surgery | www.frontiersin.org 7 December 2018 | Volume 5 | Article 76
Campi et al. Templates of Lymphadenectomy for Renal Cancer
removal of inter-aortocaval and retrocaval nodes only in the last
group of patients included in the series (25). Notably, Abaza et al.
showed the feasibility of performing LND for right-sided tumors
including paracaval, retrocaval, and inter-aortocaval nodes using
a robotic approach (29).
The study by Nini et al. evaluated the pattern of nodal
metastatic dissemination from RCC in a cohort of patients
undergoing extended LND including removal of hilar,
pre/paracaval and inter-aortocaval nodes (39). The authors
found that, in case of right-sided tumors, the positive LNs were
located in the paracaval, interaortocaval, and renal hilar regions
in 44, 40, and 16% of cases, respectively. When two nodal areas
were involved, they included the paracaval + interaortocaval
regions in 87% of cases. It is important to highlight that in their
retrospective cohort study, Crispen et al. reported that, despite
the location of LN metastases was related to the tumor side,
45% of patients with pN+ disease had no metastases in the
perihilar nodes and no patient with a right-sided tumor had
involvement of the para-aortic LNs without metastases in other
retroperitoneal lymph nodes (28).
Templates of Lymph Node Dissection for
Left-Sided RCC
For left-sided tumors, the most commonly dissected anatomical
templates were the renal hilar, pre/para aortic (i.e., on the anterior
and lateral side of the aorta) from the crus of the diaphragm to the
aortic bifurcation (Table 1). Of note, only few authors reported
a systematic dissection of a more extended template including
inter-aortocaval (8, 19, 25, 28–30, 34, 35, 39), retro-aortic (19–
21, 23, 27, 28, 37), common iliac (25), or even para-caval (28)
nodes. A LND template including periaortic and interaortocaval
nodes was also described by Abaza et al. in their study including
patients undergoing robotic LND (29). In their study on extended
LND, Nini et al. reported that positive LNs from left-sided tumors
were located in the pre/paraaortic, interaortocaval, and renal
hilar regions in 67, 9, and 24% of cases (39). When two nodal
areas were involved, they included the pre/paraaortic + renal
hilar regions in 91% of cases. Of note, in the retrospective study
by Crispen et al. (28), no patient with a left-sided tumor had
positive paracaval LNs without involvement of para-aortic or
interaortocaval nodes.
Mapping Studies Using the Sentinel Node
Technique Assessing the Pattern of
Lymphatic Drainage From RCC
Two studies included in the review were specifically designed
to evaluate the pattern of lymphatic drainage from RCC using
sequential lymphoscintigraphy and sentinel node biopsy (30, 37).
In the largest prospective phase II single-arm study evaluating
the distribution of sentinel LNs and the lymphatic drainage
pattern of renal tumors in vivo with SPECT, Kuusk et al. found
that drainage from right-sided tumors was predominantly into
inter-aortocaval and retrocaval sentinel nodes (37). Moreover,
6/18 (33%) patients with right-sided tumors had simultaneous
drainage to interaortocaval, retrocaval, left preaortic or para-
aortic, and left supraclavicular lymph nodes. Only three patients
had sentinel LNs in the right paracaval and renal hilar and
no patient to precaval LNs. The distribution of sentinel LNs
from left-sided tumors revealed that the lymphatic drainage
was mainly into para-aortic LNs and that very few patients
had direct left hilar sentinel LNs (37). Moreover, 9/22 (41%)
had simultaneous renal hilar, mediastinal, left supraclavicular,
retrocrural, left common iliac, renal fossa, and interaortocaval
sentinel LNs.
DISCUSSION
Lymph node dissection has staging, prognostic and potentially
therapeutic roles in several urologic malignancies, including
prostate (40), bladder (41), testis (42), and upper tract urothelial
(16) tumors. Of note, its role in the management of RCC is
still debated (3–5, 7). Accordingly, a recent large European
multi-institutional study reported a trend toward lower rates
of LND over time for patients undergoing radical or partial
nephrectomy for RCC (43). Themost recent systematic review on
this topic (3) concluded that, although LND yields independent
prognostic information, the existing literature does not support a
therapeutic benefit in either non-metastatic or metastatic RCC.
Nonetheless, LND may have a role in selected high-risk non-
metastatic patients, for whom further prospective studies are
warranted (3). Indeed, the extent of LND has been shown to affect
cancer-specific survival and metastatic progression in specific
sub-categories of patients with RCC (10).
This conflicting evidence on the benefits and harms of LND
for RCC (1, 9, 11, 44), which directly impacts the strengths of
Guidelines recommendations (4, 5, 7), is inherently linked to
the lack of consensus on both anatomic templates and extent
of lymphadenectomy (4). In this regard, some authors advocate
routine extended LND (if indicated) (6); yet, the potential
oncologic benefits should be balanced with the increased risk
of surgical complications, which may be not negligible in this
setting (45). Beyond the lack of standardized reporting of surgical
templates of LND in the literature (including the only RCT
available to date (1, 2, 14, 15), the complex anatomy of lymphatic
drainage from RCC undermines a thorough understanding of the
anatomic sites of lymphatic involvement.
Therefore, in this review we provided a detailed assessment
of the most commonly dissected templates of LND for RCC,
focusing on the key anatomic landmarks and on the putative
patterns of lymphatic drainage, as suggested by availablemapping
studies.
The available autopsy studies underscore the unpredictable
variability of drainage patterns and the heterogeneity of
lymphatic metastases from RCC; as such, they provided only
limited evidence for defining effective LND templates to date
(1, 12, 13, 46–48). Overall, four critical issues should be
considered when evaluating potential anatomic templates of
LND for RCC. First, the presence of anterior, intravascular,
and posterior bundles of efferent lymphatic vessels from both
the right and left kidney, whose drainage pattern is still not
completely understood (12). These efferent lymphatics drain into
paracaval, precaval, retrocaval, and interaortocaval nodes, for
right-sided tumors, and into paraaortic, preaortic, and retroaortic
nodes, for left-sided tumors (13, 46). Second, the existence of
peripheral lymphovenous communication sites located in the
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inferior vena cava at the level of the renal veins or through the
thoracic duct (12); these communications may imply LN station
skipping and explain how distant metastases can occur without
concurrent retroperitoneal LN involvement (14, 46). Third, the
effects of local tumor growth may be responsible for further
unpredictability (2). Finally, renal hilar regions have been shown
to be rarely affected by LN metastases (49, 50).
The anatomy of lymphatic drainage from RCC has been
also investigated in vivo taking advantage of sentinel LN
biopsy (12, 30, 37, 51). Although this technique may be
theoretically challenged by tumor lymphangiogenesis and
lymphatic remodeling, the largest mapping study available
to date showed that drainage from right-sided tumors was
predominantly into inter-aortocaval and retrocaval sentinel
nodes while drainage from left-sided tumors mainly into para-
aortic LNs (37). Moreover, only a negligible proportion of
patients had sentinel LNs in the ipsilateral renal hilar regions.
Our review provides relevant information to better
contextualize the current evidence on anatomic templates
of LND for RCC.
A key finding is that the surgical template for LND was
heterogenous across the included studies and only a minority of
reports described the specific anatomic location (and number)
of positive nodes within the template (Table 1). Moreover,
indications and extent of LND were either not reported
or not standardized in most series and relied mainly on
surgeon’s judgement. An additional finding is that the most
commonly dissected template for right-sided tumors included
hilar, paracaval, and precaval nodes, with few authors extending
the dissection to the inter-aortocaval, retrocaval, common iliac,
or pre/paraaortic nodes (Table 1). As such, considering the
findings of the available mapping studies using the SN technique
(30, 37) as well as those of studies reporting an extended LND
in high-risk patients (28, 39), the extent of the most commonly
dissected templates for right-sided tumors (especially if advanced
in stage) might be insufficient to catch the comprehensive pattern
of lymphatic drainage, which frequently involves the retro-
caval and inter-aorto-caval sites. Similarly, the most commonly
dissected template for left-sided tumors encompassed the renal
hilar, pre/para aortic nodes, with few authors reporting a
systematic dissection of inter-aortocaval, retro-aortic, common
iliac, or para-caval nodes (Figure 1). In conclusion, in light of the
above discussed anatomic considerations, the templates of LND
most commonly dissected for both right- and left-sided tumors
might be unable to capture the complexity of the LN drainage
from RCC. This concept is reflected in the relatively low number
of LNs removed in most of the included studies (Table 1).
The findings from our review should be interpreted in light of
several limitations at both a review- and study-level. Our review
was not designed to assess the association of LND templates
with positive LNs and key oncologic outcomes after surgery
for RCC. As such, we were unable to evaluate the potential
impact of extent of LND and cancer-specific or overall survival
after surgery. Second, the review strategy might not have been
able to identify all relevant studies on the topic of interest. In
particular, a limitation of our review is that studies that did
not fulfill the pre-specified eligibility criteria (including detailed
reporting of anatomical LND templates) were excluded from
the qualitative synthesis. Therefore, studies that attempted to
address the role of extended vs. limited LND which did not
adequately report the anatomic sites of LND were not included
in our review. Third, most studies included in qualitative analysis
were retrospective, subject to selection bias. Moreover, patient
populations, surgical approaches, techniques for LND and quality
of reporting LND results were highly heterogeneous across
included studies, reducing the generalizability of findings. In this
regard, due to the low number of series reporting LND during
robotic or laparoscopic surgery, the above mentioned LND
templates may not be entirely applicable to minimally-invasive
surgery. Finally, it was not possible to evaluate the potential
association between number of LNs removed (which has been
associated with rate of LNmetastases and cancer-specific survival
(10, 11, 22) and anatomic extent of LND template, due to the lack
of this information in most series.
Our review affords opportunities for significant further
research in this field. In particular, future RCTs should evaluate
the benefits and harms of extended LND using standardized
anatomic templates in patients with high-risk RCC, where LND
may significantly impact on the disease course (45). Such studies
should aim to build an evidence-based consensus on the surgical
management of retroperitoneal nodes in patients with RCC,
overcoming the complexity of renal lymphatic anatomy. To this
aim, an effective study design should compare extended vs. no
LND to avoid risk of misclassification of pN status due to the
confounding effect of a limited LND arm (52). Future mapping
studies should improve in vivo evaluation of lymphatic drainage
from RCC, taking advantage of sentinel node (37) and frozen
section analysis (27), novel technologies (including indocyanine
green fluorescent lymphography) and advanced multimodality
imaging (12). Finally, further research should explore the role of
LND during minimally-invasive surgery to assess the feasibility
and outcomes of extended surgical templates.
CONCLUSIONS
The conflicting evidence on the benefits and harms of LND for
RCC is inherently linked to the lack of consensus on anatomic
templates and extent of lymphadenectomy. In this review, we
provided an overview of the most commonly dissected templates
of LND, focusing on key anatomic landmarks and patterns
of lymphatic drainage. The surgical template for LND was
heterogenous across included studies, and indications and extent
of LND were either not reported or not standardized in most
series.
For right-sided tumors, the most commonly dissected
templates were the hilar, paracaval, and precaval nodes, while
for left-sided tumors, the renal hilar, pre/para aortic nodes, both
from the crus of the diaphragm to the aortic bifurcation.
In light of the unpredictable renal lymphatic anatomy and
considering the evidence from available prospective mapping
studies, which suggest that lymphatic drainage from renal tumors
may be directed predominantly to inter-aortocaval and retrocaval
nodes—on the right side—and para-aortic and inter-aortocaval
nodes—on the left side, the extent of the most commonly
dissected templates might be insufficient to catch the overall
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anatomic pattern of lymphatic drainage from RCC, especially for
higher stage and right-sided tumors.
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